首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
首頁 > 市場調查報告書 > 製藥 > 製藥企業 > 利用PLM（產品生命週期管理）的藥品產業流程複雜性管理
產業/市場分類
製藥 (4495)
肥胖症治療 (48)
非專利藥 (117)
疫苗 (168)
神經疾病 (175)
骨頭疾病治療 (41)
動物用醫藥 (18)
處方藥 (89)
規章 (107)
感染疾病 (318)
精神病 (80)
製藥企業 (506)
糖尿病 (157)
癌症 (838)
藥物開發 (1275)
DDS (173)
OTC 非處方藥 (147)
市場調查報告書

利用PLM（產品生命週期管理）的藥品產業流程複雜性管理

Managing Process Complexity in the Pharmaceutical Industry with PLM (Strategy Focus)

出版商 Datamonitor
出版日期 2007年08月 商品編碼 55084
內容資訊 英文  
價格
本報告書已不再販售

本報告已在2011年07月19日停止出版。

簡介

專門於多樣市場領域之調查分析的英國市調公司 Datamonitor Corporation（總公司：London），針對利用PLM的藥品產業流程複雜性管理進行相關調查分析及預測，並出版報告書 "Managing Process Complexity in the Pharmaceutical Industry with PLM (Strategy Focus)" 。

本報告書內容包括：藥品產業PLM（產品生命週期管理）銷售企業的銷售策略及有效的關係建構、銷售企業特性等。內容綱要摘記如下：

概要

分析

  • 藥品生命週期管理技術快速發展
    • 藥品產業採用PLM時將面臨各種課題
    • 文化及技術障礙將阻撓在藥品市場中大規模地採用PLM
    • 藥品產業的PLM在大幅成長的銷售企業中扮演重要的角色
  • 生命科學領域的PLM應在管理流程複雜性的同時回應商業流程的需要
    • 製藥企業應去發現而不是發明
    • 藥品部門正尋找能管理複雜流程的PLM
  • 企業將PLM視為策略性工具將獲得成功
    • 管理階層將PLM視為企業產品開發商業策略的一部份
    • 透過針對企業的PLM突破個別合作方法
    • 企業型PLM解決方案的優點也帶有風險
    • 階段性採用方法是藥品產業最偏好的方式
  • 與技術開發業者合作是必要的策略
    • 長期投入計畫的承諾就是表示願意負擔相對的風險
    • 創新且靈活的銷售企業能創造更多的事業機會
    • 效率是重要的銷售企業特性
    • 成功經驗將有助於建立銷售企業的信用
  • 行動方案
    • PLM必須有助於經營層做決策
    • 在擁有長期遠光的同時也應設定短期的里程碑
    • 為建立對PLM的策略方針，應持有超越重點解決方案的觀點

附錄

目錄

Abstract

Overview

Introduction

Product lifecycle management (PLM) software and services solutions are still a nascent market for the pharmaceutical industry. Datamonitor believes that unless the industry adopts a strategic approach to PLM, the technology will remain a tactical solution whose potential is not maximized.

Scope

  • Examines essential ingredients of sales strategies for PLM vendors serving the pharmaceutical industry
  • Identifies strategies vendors should use to develop more effective relationships and win business from life science companies
  • Offers insight into the vendor attributes valued most by pharmaceutical companies when selecting a vendor

Report Highlights

Pharmaceutical product lifecycle management technology is gaining momentum

PLM in the life sciences should map to business processes, managing process complexity

PLM is successful when treated as an enterprise, strategic initiative

Reasons to Purchase

  • Understand how to position PLM solutions when targeting pharmaceutical and biotechnology companies
  • Discover new ways to leverage relationships as a tool to drive market penetration
  • Gain insight into Datamonitor' s perspective on what makes a vendor successful

Table of Contents

  • DATAMONITOR VIEW
    • CATALYST
    • SUMMARY
  • ANALYSIS
    • Pharmaceutical product lifecycle management technology is gaining momentum
      • A variety of challenges is fueling PLM adoption in the pharmaceutical industry
      • Cultural and technological barriers have inhibited wider adoption of PLM in the pharmaceutical market
      • PLM in the pharmaceutical industry is poised for strong growth and vendors have an important role to play
    • PLM in the life sciences should map to business processes, managing process complexity
      • Pharmaceutical companies produce what they discover, not what they invent
      • The pharmaceutical sector looks for PLM that can manage process complexity
    • PLM is successful when handled as an enterprise, strategic initiative
      • As part of a company' s product development business strategy, PLM is discussed among executives
      • Collaboration, through enterprise PLM, breaks down individual silos
      • Reducing drug development costs is a major strategic goal for implementing enterprise PLM
      • The benefits of an enterprise-wide PLM solution do come with risks
      • A phased implementation approach is most likely for pharmaceutical organizations
    • Partnering with a technology vendor may be a necessary PLM strategy
      • A long-term commitment to the project indicates a willingness to share risk
      • Innovative and flexible vendors will attract most business
      • Implementation efficiency is an important vendor characteristic
      • Track record of success reflects on a vendor' s reliability and trustworthiness
  • ACTIONS
    • PLM must support executive-level decisions
    • Have a long-term vision but establish short-term milestones
    • Look beyond point solutions for a strategic approach to PLM
  • APPENDIX
  • APPENDIX
    • Definitions
    • Abbreviations
    • Methodology
    • Further reading
    • Ask the analyst
    • Datamonitor consulting
    • Disclaimer
    • List of Figures
      • Figure 1: In the pharmaceutical industry, complexity in the process defines the product
      • Figure 2: Making a value proposition for PLM as a strategy in the pharmaceutical product lifecycle
      • Figure 3: As the Big Pharma begins to face its information management needs, enterprise PLM investments will grow
      • Figure 4: Examples of "must-have" and "nice-to-have" criteria pharmaceutical companies use for selecting a PLM vendor as potential partner
Back to Top